Florez Focuses on Patient-Centered NSCLC Biomarker Testing Discussions

Season 11 Episode 10  ·  Sep 05, 2024, 06:34 PM

Headliner
Share
Subscribe
In today’s episode, we had the pleasure of speaking with Narjust Florez, MD, about patient-focused lung cancer biomarker testing discussions.
Share
Subscribe
Next
Heme & Onc Fellow Board Review Tips 2024
Top episodes
DeNunzio Describes the Advantages of Proton Beam Therapy in Oncology
by OncLive® On Air
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air